[ARTICLE] 5
[PERIOD-TYPE] 3-MOS 3-MOS
9-MOS 9-MOS
[FISCAL-YEAR-END] DEC-31-1995 DEC-31-1994
DEC-31-1995 DEC-31-1994
[PERIOD-START] JUL-01-1995 JUL-01-1994
JAN-01-1995 JAN-01-1994
[PERIOD-END] SEP-30-1995 SEP-30-1994
SEP-30-1995 SEP-30-1994
Net income (loss) (203,224)
(236,369) (324,943) (396,930)
Cumulative undeclared dividends
on preferred stock (6,135)
(6,175) (18,404) (18,524)
Dividends declared -- --
-- --
__________________________________________________
Net income (loss) available
to common shareholders (209,359)
(242,544) (343,347) (415,454)
Cumulative undeclared dividends
on preferred stock 6,135 6,175
18,404 18,524
Interest on convertible debenture 30,000 30,000
90,000 90,000
Interest on convertible promissory notes -- 4,413
10,041 12,595
Interest forgiven on convertible notes -- --
(33,395) --
____________________________________________________
Net loss assuming full dilution (173,224)
(201,956) (258,297) (294,335)
____________________________________________________
____________________________________________________
Weight average number of shares outstanding 13,668,781
13,001,904 13,253,507 12,988,644
COMMON STOCK EQUIVALENTS (see note below):
OPTIONS AND WARRANTS (COMPUTED BY APPLICATION
OF THE "TREASURY STOCK METHOD")
Employee stock options -- 212,236
-- 228,070
Warrants for 800,000 shs. @$0.25 expiring 2/1, -- 345,455
-- 407,843
Warrants for 680,667 shs. @$0.75 expiring 6/26, -- --
-- --
Warrants for 252,600 shs. @$0.75 expiring 6/26, -- --
-- --
OTHER COMMON STOCK EQUIVALENTS:
Convertible promissoary notes with warrants 3,995,374
1,316,546 3,995,374 1,316,546
subject to conversion
Convertible debenture 375,000
375,000 375,000 375,000
Redeemable preferred stock 76,684
77,184 76,684 77,184
_____________________________________________________
Shares outstanding assuming full dilution 18,115,839
15,328,325 17,700,565 15,393,287
_____________________________________________________
_____________________________________________________
Loss per common share (0.02)
(0.02) (0.03) (0.03)
_____________________________________________________
_____________________________________________________
Note: Primary and fully diluted loss per share have not been presented
since the effect of common stock
equivalents is anti-dilutive.